 Salmeterol nocturnal asthma double blind placebo trial long acting agonist OBJECTIVE inhaled salmeterol new long acting beta adrenergic agonist nocturnal bronchoconstriction sleep quality patients nocturnal asthma DESIGN double blind placebo crossover study SETTING Hospital outpatient clinics Edinburgh SUBJECTS Twenty stable patients women men nocturnal asthma median age years INTERVENTIONS Salmeterol micrograms micrograms placebo morning evening dose inhaler Rescue salbutamol inhalers run periods MAIN OUTCOME MEASURES Improvement nocturnal asthma peak expiratory flow rates change sleep quality electroencephalography RESULTS Salmeterol overnight peak flow rate micrograms difference median values confidence interval difference medians l/min micrograms l/min twice salmeterol micrograms daily patients objective improvement sleep quality time awake light sleep min time stage sleep min CONCLUSIONS Salmeterol effective long inhaled bronchodilator patients nocturnal asthma dose micrograms daily improves objective sleep quality